80 FR 10702 - National Heart, Lung, and Blood Institute; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 39 (February 27, 2015)

Page Range		10702-10702
FR Document		2015-04055

Federal Register, Volume 80 Issue 39 (Friday, February 27, 2015)

[Federal Register Volume 80, Number 39 (Friday, February 27, 2015)]
[Notices]
[Page 10702]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-04055]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Heart, Lung, and Blood Initial Review Group; 
Heart, Lung, and Blood Program Project Review Committee.
    Date: March 20, 2015.
    Time: 8:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Jeffrey H. Hurst, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, National Institutes of Health, 6701 Rockledge 
Drive, Room 7208, Bethesda, MD 20892, 301-435-0303, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: February 23, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-04055 Filed 2-25-15; 8:45 am]
BILLING CODE 4140-01-P

10702 Federal Register / Vol. 80, No. 39 / Friday, February 27, 2015 / Notices

Place: Hilton Garden Inn Washington DC/ Contact Person: Kristin Goltry, Ph.D., Review/DERA, National Heart, Lung, and
Bethesda, 7301 Waverly Street, Bethesda, MD Scientific Review Officer, Office of Scientific Blood Institute, National Institutes of Health,
20814. Review/DERA, National Heart, Lung, and 6701 Rockledge Drive, Room 7208, Bethesda,
Contact Person: YingYing Li-Smerin, MD, Blood Institute, 6701 Rockledge Drive, Room MD 20892, 301–435–0303, hurstj@
Ph.D., Scientific Review Officer, Office of 7198, Bethesda, MD 20892, 301–435–0297, nhlbi.nih.gov.
Scientific Review/DERA, National Heart, goltrykl@mail.nih.gov. (Catalogue of Federal Domestic Assistance
Lung, and Blood Institute, 6701 Rockledge Name of Committee: National Heart, Lung, Program Nos. 93.233, National Center for
Drive, Room 7184, Bethesda, MD 20892– and Blood Institute Special Emphasis Panel; Sleep Disorders Research; 93.837, Heart and
7924, 301–435–0277, lismerin@nhlbi.nih.gov. Bioreactor Technology. Vascular Diseases Research; 93.838, Lung
Name of Committee: National Heart, Lung, Date: March 17, 2015. Diseases Research; 93.839, Blood Diseases
and Blood Institute Special Emphasis Panel; Time: 11:00 a.m. to 3:00 p.m. and Resources Research, National Institutes
Pulmonary Trials Cooperative. Agenda: To review and evaluate grant of Health, HHS)
Date: March 20, 2015. applications.
Time: 9:00 a.m. to 4:00 p.m. Place: Bethesda Marriott Suites, 6711 Dated: February 23, 2015.
Agenda: To review and evaluate grant Democracy Boulevard, Bethesda, MD 20817. Michelle Trout,
applications. Contact Person: Kristin Goltry, Ph.D., Program Analyst, Office of Federal Advisory
Place: Residence Inn Bethesda, 7335 Scientific Review Officer, Office of Scientific Committee Policy.
Wisconsin Avenue, Bethesda, MD 20814. Review/DERA, National Heart, Lung, and
[FR Doc. 2015–04055 Filed 2–25–15; 8:45 am]
Contact Person: Kristen Page, Ph.D., Blood Institute, 6701 Rockledge Drive, Room
Scientific Review Officer, Office of Scientific 7198, Bethesda, MD 20892, 301–435–0297, BILLING CODE 4140–01–P
Review/DERA, National Heart, Lung, and goltrykl@mail.nih.gov.
Blood Institute, 6701 Rockledge Drive, Room (Catalogue of Federal Domestic Assistance
7185, Bethesda, MD 20892, 301–435–0725, Program Nos. 93.233, National Center for DEPARTMENT OF HEALTH AND
kristen.page@nih.gov. Sleep Disorders Research; 93.837, Heart and HUMAN SERVICES
(Catalogue of Federal Domestic Assistance Vascular Diseases Research; 93.838, Lung
Program Nos. 93.233, National Center for Diseases Research; 93.839, Blood Diseases National Institutes of Health
Sleep Disorders Research; 93.837, Heart and and Resources Research, National Institutes
Vascular Diseases Research; 93.838, Lung of Health, HHS) National Cancer Institute; Notice of
Diseases Research; 93.839, Blood Diseases Dated: February 23, 2015. Closed Meetings
and Resources Research, National Institutes
of Health, HHS) Michelle Trout,
Pursuant to section 10(d) of the
Program Analyst, Office of Federal Advisory Federal Advisory Committee Act, as
Dated: February 23, 2015.
Committee Policy.
Michelle Trout, amended (5 U.S.C. App.), notice is
[FR Doc. 2015–04053 Filed 2–26–15; 8:45 am]
Program Analyst, Office of Federal Advisory hereby given of the following meetings.
BILLING CODE 4140–01–P
Committee Policy. The meetings will be closed to the
[FR Doc. 2015–04056 Filed 2–26–15; 8:45 am] public in accordance with the
BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND provisions set forth in sections
HUMAN SERVICES 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications/
DEPARTMENT OF HEALTH AND National Institutes of Health contract proposals and the discussions
HUMAN SERVICES could disclose confidential trade secrets
National Heart, Lung, and Blood or commercial property such as
National Institutes of Health Institute; Notice of Closed Meeting patentable material, and personal
Pursuant to section 10(d) of the information concerning individuals
National Heart, Lung, and Blood
Federal Advisory Committee Act, as associated with the grant applications,
Institute; Notice of Closed Meetings
amended (5 U.S.C. App.), notice is the disclosure of which would
Pursuant to section 10(d) of the hereby given of the following meeting. constitute a clearly unwarranted
Federal Advisory Committee Act, as The meeting will be closed to the invasion of personal privacy.
amended (5 U.S.C. App.), notice is public in accordance with the Name of Committee: National Cancer
hereby given of the following meetings. provisions set forth in sections Institute Special Emphasis Panel; IMAT
The meetings will be closed to the 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Biospecimen Science Part 2.
public in accordance with the as amended. The grant applications and Date: March 17, 2015.
provisions set forth in sections the discussions could disclose Time: 11:00 a.m. to 2:00 p.m.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., confidential trade secrets or commercial Agenda: To review and evaluate grant
as amended. The grant applications and applications.
property such as patentable material, Place: National Cancer Institute Shady
the discussions could disclose and personal information concerning
confidential trade secrets or commercial Grove, 9609 Medical Center Drive, Room
individuals associated with the grant 2E030, Rockville, MD 20850, (Telephone
property such as patentable material, applications, the disclosure of which Conference Call).
and personal information concerning would constitute a clearly unwarranted Contact Person: Donald L. Coppock, Ph.D.,
individuals associated with the grant invasion of personal privacy. Scientific Review Officer, Research
applications, the disclosure of which Technology and Contract Review Branch,
would constitute a clearly unwarranted Name of Committee: Heart, Lung, and
Blood Initial Review Group; Heart, Lung, and Division of Extramural Activities, National
invasion of personal privacy. Blood Program Project Review Committee. Cancer Institute, 9609 Medical Center Drive,
Room 7W260, Bethesda, MD 20892, 240–
mstockstill on DSK4VPTVN1PROD with NOTICES

Name of Committee: National Heart, Lung, Date: March 20, 2015.
and Blood Institute Special Emphasis Panel; Time: 8:00 a.m. to 2:00 p.m. 276–6382, donald.coppock@nih.gov.
Bioreactor Technology. Agenda: To review and evaluate grant Name of Committee: National Cancer
Date: March 17, 2015. applications. Institute Special Emphasis Panel; Omnibus
Time: 9:00 a.m. to 11:00 a.m. Place: Hyatt Regency Bethesda, One SEP–5.
Agenda: To review and evaluate grant Bethesda Metro Center, 7400 Wisconsin Date: March 26–27, 2015.
applications. Avenue, Bethesda, MD 20814. Time: 8:00 a.m. to 5:00 p.m.
Place: Bethesda Marriott Suites, 6711 Contact Person: Jeffrey H. Hurst, Ph.D., Agenda: To review and evaluate grant
Democracy Boulevard, Bethesda, MD 20817. Scientific Review Officer, Office of Scientific applications.

VerDate Sep<11>2014 18:05 Feb 26, 2015 Jkt 235001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\27FEN1.SGM 27FEN1

Document Created: 2015-12-18 13:15:02
Document Modified: 2015-12-18 13:15:02

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		March 20, 2015.
FR Citation		80 FR 10702

80 FR 10702 - National Heart, Lung, and Blood Institute; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 39 (February 27, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health